Home » Topics » BioWorld Science

BioWorld Science
RSS

NIAID initiates phase I study of SeVRSV vaccine

May 24, 2018

European Commission approves Sandoz's infliximab biosimilar Zessly

May 24, 2018

Bicycle Therapeutics expands collaboration with AstraZeneca

May 24, 2018

MIW-815 elicits strong and durable cancer immunity

May 24, 2018

Esperion's third pivotal study of bempedoic acid meets primary endpoint

May 24, 2018

DSMB recommends continuation of phase II study of Xanamem in Alzheimer's disease

May 24, 2018

Clinical results reported for bifunctional short-hairpin RNA for Ewing's sarcoma

May 24, 2018

Targeting TGF-beta-1 prevents pulmonary fibrosis in rats

May 24, 2018

FDA approves Yonsa for metastatic CRPC

May 24, 2018

PanOptica initiates phase I/II trial of PAN-90806 in wet AMD

May 24, 2018

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...